ABOUT

SCIENCE

PATIENTS

Vitalgen is committed to developing innovative cell and gene therapies for the treatment of blood and metabolic disorders, neurodegenerative diseases, retinal diseases and cancers.

Gene Therapy
Discovery
Optimization
IND-enabling
Clinical Stage
VGB-R04
HB
VGR-R01
BCD
VGM-R02b
GA-1
VGM-R11
VGN-R08
VGN-R09
Gene Editing
Discovery
Optimization
IND-enabling
Clinical Stage
VGR-E01
VGB-E06
Note 1:      Investigator Initiated Trials (IITs) ongoing
Note 2:      Orphan Drug Designation;       Rare Pediatric Disease Designation
Note 3:Over 10 programs in the early stage of development